Dose MTX-based chemotherapy followed by consolidating radiotherapy in Non-Aids related Primary Central Nervous System Lymphoma.

被引：0
|
作者：
Kluin-Nelemans, JC
Poortmans, P
Haaxma-Reicher, H
van't Veer, MB
Hansen, M
Taphoorn, MJ
Thomas, J
Soubeyran, P
Fickers, M
Loosveld, OJ
Roerdink, HT
van den Bent, MJ
van Imhoff, GW
Teodorovic, I
Rozewicz, C
Van Glabbeke, MM
Raemaekers, JM
机构：
[1] Acad Hosp Groningen, Groningen, Netherlands
[2] Dr Bernard Verbeeten Inst, Tilburg, Netherlands
[3] Erasmus Med Ctr, Daniel Den Hoed Klin, Rotterdam, Netherlands
[4] Rigshosp, DK-2100 Copenhagen, Denmark
[5] Univ Med Ctr, Utrecht, Netherlands
[6] UZ Gasthuisberg, Louvain, Belgium
[7] Inst Bergonie, Bordeaux, France
[8] Atrium Med Ctr, Heerlen, Netherlands
[9] Twee Steden Ziekenhuis, Tilburg, Netherlands
[10] Eortc Data Ctr, Brussels, Belgium
[11] Univ Med Ctr, Nijmegen, Netherlands
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3071
引用
收藏
页码：776A / 777A
页数：2
相关论文
共 50 条
  • [1] Preliminary results of combined chemotherapy and radiotherapy for non-AIDS primary central nervous system lymphoma
    OBrien, PC
    Roos, DE
    Liew, KH
    Trotter, GE
    Barton, MB
    Walker, QJ
    Poulsen, MG
    Olver, IN
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1996, 165 (08) : 424 - 427
  • [2] PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA IN AIDS AND NON-AIDS
    POON, TP
    MATOSO, I
    TCHERTKOFF, V
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1987, 88 (04) : 529 - 530
  • [3] Ongoing Protocols for Non-AIDS Primary Central Nervous System Lymphoma
    Khê Hoang-Xuan
    Jean-Yves Delattre
    [J]. Journal of Neuro-Oncology, 1999, 43 : 287 - 291
  • [4] Ongoing protocols for non-AIDS primary central nervous system lymphoma
    Hoang-Xuan, K
    Delattre, JY
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1999, 43 (03) : 287 - 291
  • [5] High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European organization for research and treatment of cancer lymphoma group phase II trial 20962
    Poortmans, PMP
    Kluin-Nelemans, HC
    Haaxma-Reiche, H
    Van't Veer, M
    Hansen, M
    Soubeyran, P
    Taphoorn, M
    Thomas, J
    Van den Bent, M
    Fickers, M
    Van Imhoff, G
    Rozewicz, C
    Teodorovic, I
    van Glabbeke, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) : 4483 - 4488
  • [6] HIGH-DOSE METHOTREXATE FOR NON-AIDS PRIMARY CENTRAL NERVOUS-SYSTEM LYMPHOMA - REPORT OF 13 CASES
    GABBAI, AA
    HOCHBERG, FH
    LINGGOOD, RM
    BASHIR, R
    HOTLEMAN, K
    [J]. JOURNAL OF NEUROSURGERY, 1989, 70 (02) : 190 - 194
  • [7] High dose methotrexate based chemotherapy in renal transplant recipients with primary central nervous system lymphoma.
    Chitalkar, PG
    Kapur, B
    Rajvanshi, A
    Munshi, N
    [J]. BLOOD, 2003, 102 (11) : 285B - 285B
  • [8] Prognostic factors for survival in acquired immunodeficiency syndrome (AIDS) and non-AIDS related patients with primary central nervous system lymphoma (PCNSL).
    Raez, L
    Patel, P
    Raub, W
    Cassileth, P
    [J]. BLOOD, 1997, 90 (10) : 3943 - 3943
  • [9] EBV-targeted therapy for AIDS-related primary central nervous system lymphoma.
    Freiberg, AS
    Slobod, KS
    Taylor, GH
    Sandlund, JT
    Thompson, S
    Furth, P
    Gan, YJ
    Helton, KJ
    Sixby, JW
    [J]. BLOOD, 2000, 96 (11) : 139A - 139A
  • [10] PRIMARY NON-AIDS RELATED BRAIN LYMPHOMA - PATTERNS OF FAILURE FOLLOWING RADIOTHERAPY
    UEMATSU, M
    KONDO, M
    DOKIYA, T
    OGUCHI, Y
    TOYA, S
    TORIKATA, C
    KURIBAYASHI, T
    HASHIMOTO, S
    [J]. ACTA ONCOLOGICA, 1992, 31 (05) : 551 - 554
12345